Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome. - Wikidata - wikimedia - TriplyDB

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

http://www.wikidata.org/entity/Q37547496

about

Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.

P2860

Q42086661-BF4EE182-A1AF-4811-8602-4EEB7180CF92

P2860

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

http://www.wikidata.org/entity/Q37547496

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serological and genetic comple ...... ted hemolytic uremic syndrome.

@en

Serological and genetic comple ...... ted hemolytic uremic syndrome.

@nl

type

label

Serological and genetic comple ...... ted hemolytic uremic syndrome.

@en

Serological and genetic comple ...... ted hemolytic uremic syndrome.

@nl

prefLabel

Serological and genetic comple ...... ted hemolytic uremic syndrome.

@en

Serological and genetic comple ...... ted hemolytic uremic syndrome.

@nl

P1433

Q37547496-212D6A36-3ED7-403F-8115-9E37E6CCAD26

P1476

Q37547496-1522819B-47A5-4A0A-B9F7-8C364BAAFC05

P2093

Q37547496-2998FAF9-4D63-4B35-8DA1-240B309C4144

Q37547496-39BC087A-D86C-4B25-9898-041EF9911879

Q37547496-42DF515E-3F7A-4F68-A7AA-434FEC528CE8

Q37547496-613806AA-0574-45F2-A245-7D7A54D37731

Q37547496-92B356B8-2524-48D7-B443-E4A562335EDE

Q37547496-9DFFAB21-8616-4C74-BC7F-FFEFB77793D2

Q37547496-CDB3B3BB-AC42-433B-B753-6A21FB55091B

Q37547496-D6C8CDA1-1AF7-4FBD-B0C5-2F223B5D0CC4

Q37547496-D8F60439-E32F-4BC1-BE41-303D83D7583E

Q37547496-D92D1691-5921-4FA0-B36F-DA061973A651

P2860

Q37547496-014164A1-CE90-4BED-9D95-4BFD0B336613

Q37547496-26E8ADD2-54F2-4636-AACC-0C4217A3B568

Q37547496-3322FDC1-2B8B-4C5D-B25B-29970C1CE040

Q37547496-3A9843AF-5899-48F3-B0DA-9E730A2A2FD7

Q37547496-3ABE3AEB-46E0-4D97-8D63-BC1F101C21FE

Q37547496-3FEC15A4-264C-4272-B52F-9FB3F5941299

Q37547496-41BD7DDD-281E-4372-8762-0BD164E25F88

Q37547496-4C32B574-4C99-4FA1-8222-038641ABDDB7

Q37547496-4D5DC80D-F053-4DB7-B392-1FE1FD9FF464

Q37547496-4E97072D-C385-464B-B19B-9096A8E6CBA4

P2888

Q37547496-6D3D5D33-FF99-400D-B781-B729FC5EAD82

P304

Q37547496-F93E8BAC-BBA2-4233-BB44-92BF2ADD65AF

P31

Q37547496-573EE47F-B2F9-47E9-B1EC-2FC0905E48CA

P356

Q37547496-483579D6-052F-4BD6-AE69-7134DA8E622B

P433

Q37547496-3A3B0389-5E29-4C39-8906-8F1922B3D7F0

P478

Q37547496-CE26C2B1-182E-4CFD-9FBA-50095114B006

P50

Q37547496-6048094A-43EA-4293-B1F0-302307ED2214

Q37547496-D8ECD295-929A-4B05-9AD8-7FBEA0E14091

P577

Q37547496-159F084D-8E02-40B8-A4FC-EBEC59A5D4BB

P698

Q37547496-686F738A-BFDC-424E-AE8D-B5EBF7CB8E89

P932

Q37547496-B3847CEF-A4FA-49F8-886C-7C8860160E4F

P356

S00467-016-3496-0

P1433

Pediatric Nephrology

P1476

Serological and genetic comple ...... ted hemolytic uremic syndrome.

@en

P2093

Anja Roos

http://www.w3.org/2001/XMLSchema#string

Annelies Jeronimus-Klaasen

http://www.w3.org/2001/XMLSchema#string

Antonia H M Bouts

http://www.w3.org/2001/XMLSchema#string

Dineke Westra

http://www.w3.org/2001/XMLSchema#string

Eiske M Dorresteijn

http://www.w3.org/2001/XMLSchema#string

Joanna A E van Wijk

http://www.w3.org/2001/XMLSchema#string

Joop Goertz

http://www.w3.org/2001/XMLSchema#string

Lambert P van den Heuvel

http://www.w3.org/2001/XMLSchema#string

Mandy G Keijzer-Veen

http://www.w3.org/2001/XMLSchema#string

Nicole C A J van de Kar

http://www.w3.org/2001/XMLSchema#string

P2860

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Structure of complement fragment C3b-factor H and implications for host protection by complement regulators

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome

Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS)

P2888

s00467-016-3496-0

P304

297-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-016-3496-0

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Elena B Volokhina

P577

2016-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27718086

http://www.w3.org/2001/XMLSchema#string

P932

5203860

http://www.w3.org/2001/XMLSchema#string